skip to primary navigationskip to content

Cambridge Service Alliance

developing new understanding and approaches to complex service systems

Studying at Cambridge

 

Ecosystems Evolution Enabled by Technology

Ecosystem evolution enabled by technology – an example in Healthcare

Healthcare is changing – fast

The search for new business models for the Pharmaceutical industry is being driven by a number of factors:

  1. Society’s healthcare burden is growing due to populations that are living longer (and being unwell for longer)
  2. Payors want to now pay for outcomes from medicines not just for the pills
  3. Generics (launched after patent expiry) are cutting the value of established brands and markets
  4. Pharma R&D is not producing the blockbusters companies have needed to support their revenues
  5. Pharmaceutical companies are looking to switch roles from being pure manufacturers to service providers delivering outcomes

 

Is personalised medicine finally here?

IBM’s Smarter Planet concept – that increasing instrumentation and interconnections are making the world more intelligent – shows that by connecting healthcare devices such as pill dispensers, and health monitoring devices (e.g. glucose meters, etc), insight can be gained to health at the individual, and population scale.

Such insight would benefit multiple stakeholders in the healthcare ecosystem:

Patients quantify their health outcomes, and Carers receive support through reminders. 
Healthcare providers gain insight to patient health, from which to recommend appropriate interventions.  Payors benefit from lower healthcare costs and focus on patient outcomes

New players are going to change the health ecosystem

The large-scale, long-term deployment of this approach, based on an extensive collaboration between healthcare and technology could deliver:

  1. Novel analytical techniques enabling patients, HCPs, and other stakeholders to act quickly 
  2. Accelerated incorporation of analytics using advanced, predictive capabilities for pattern and context recognition into health assessment
  3. Value-based pricing for medicines based on pseudo real-time health outcomes data that will radically alter the way in which medicines are developed and priced by the pharmaceutical industry.

Contact: Amer Fasihi

Filed under: , ,

RSS Feed Latest news

December Newsletter

Dec 05, 2018

Welcome to the December 2018 edition of the Cambridge Service Alliance Newsletter

Gaining Customer Experience Insights That Matter

Nov 26, 2018

New paper on 'Gaining Customer Experience Insights That Matter' by Janet R. McColl-Kennedy, Mohamed Zaki, Katherine N. Lemon, Florian Urmetzer and Andy Neely published at Journal of Service Research

November 2018 Paper

Nov 21, 2018

November 2018 paper on 'Service business model innovation: the digital twin technology' by Veronica Martinez, Audrey Ouyang, Andy Neely, Caroline Burstall and Dav Bisessar

Webinar 12 November 2018 - Co-Creation in Practice: Objectives and Outcomes

Nov 14, 2018

In this webinar, Katharina Greve presents the Alliance September Paper on Co-Creation in Practice.

New EPSRC Doctoral Studentship Opportunity

Nov 09, 2018

New EPSRC Doctoral Studentship Opportunity on Digital technology in the service design and lifecycle with Rolls Royce

View all news

Upcoming events

Ecosystems Strategy One Day Course

Feb 05, 2019

IfM, Cambridge

Upcoming events